Nalaganje...
Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients
OBJECTIVE: The efficacy of tocilizumab (TCZ) in GCA is supported by two randomized controlled studies, in which TCZ allowed remission to be achieved after 52 weeks of treatment. However, after discontinuation of treatment, half of the patients relapsed. The aim of this study was to analyse the effic...
Shranjeno v:
| izdano v: | Rheumatol Adv Pract |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359771/ https://ncbi.nlm.nih.gov/pubmed/32685912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rap/rkaa017 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|